Orano Med
Plano
About Orano Med
Orano Med develops a new generation of targeted cancer therapies. The Orano Med company specializes in performance chelating agents, offering a broad range of products and services. The Orano Med strategy centers on creating a solid portfolio of therapies and ensuring a reliable supply of isotopes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10M+
- Total funding: $324.9M
- Last round: Corporate Round (Oct 2024)
- Website: oranomed.com
- Phone: +1 469 638 0632
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/orano-med-30355 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.